At Lotus, we believe that health is a right, not a privilege. We aim to provide access to healthcare through a multifaceted approach that includes developing a diverse and unique product portfolio.
Empowering Healthcare Worldwide
80+
R&D Pipelines
265+
Licensing Deals Signed
250+
Commercial Products
Differentiated Portfolio
We market over 250 commercial products across 90+ markets globally, with pipeline supported by our hybrid R&D+BD strategy. With expertise in high‑barrier oncology and complex generics, we focus on addressing unmet medical needs. Through targeted acquisitions and licensing of branded medicines, 505(b)(2) products, biosimilars, and NCEs, we continue to build a differentiated portfolio that bolsters treatment access for patients worldwide.
Generics
Generics
We offer a broad range of generics with a strong emphasis on oncology and immunology. With a proven track record in therapies such as Lenalidomide, Suboxone, Nintedanib, Vinorelbine softgel capsules and Semaglutide (to be launched), we are dedicated to advancing complex generics that support patient wellness and improve lives.
Our Product Catalogs
Taiwan
Therapeutic Areas
With deep R&D expertise and proven regulatory strength, we deliver differentiated therapies across multiple disease areas, with a strategic focus on the fast-evolving fields of oncology and immunology.
We strategically invest in developing and commercializing a differentiated portfolio of niche, high-complexity pharmaceuticals. Leveraging our experienced R&D team, advanced research and manufacturing capabilities, we drive a robust pipeline designed to address medical needs and remain at the frontiers of medical innovation.
Drug Risk Management Plan
Lotus implements drug risk management plans for designated products in accordance with Taiwan’s regulatory requirements. We provide documentation that includes general safety instructions, guidance for healthcare professionals, and product‑specific risk precautions. These plans are reviewed regularly to ensure medication safety and maintain regulatory compliance.
At Lotus, we are committed to your safety. While our products are designed to help, we understand that adverse events can sometimes occur. We continuously monitor the safety of our products and value your feedback. By sharing your experience, you help us enhance product safety and contribute to the protection of patient and public health.
CRO Services
Norwich Clinical Services offers comprehensive clinical research solutions to the pharmaceutical and biotech industries, specializing in Bioavailability/Bioequivalence Studies, Clinical Trials, Pharmacovigilance, Bioanalytical Services, and Training. Our expert team based in Bangalore, India, ensures precision and efficiency in delivering reliable results.
Our unique combination of clinical expertise, therapeutic experience, equipment and processes makes us able to manage and overcome challenges with specific focus on maximizing project budgets and meeting timelines.
